Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Biosimilar Monoclonal Antibody industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Therapeutics SA
Coherus BioSciences Inc
Boehringer Ingelheim GmbH
Intas Pharmaceuticals Limited
BIOCAD BioXpress
Allergan plc
Celltrion Inc
Dr Reddys Laboratories Ltd
Genor BioPharma Co Ltd
Biocon Limited
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Synthetic Chemicals
Biopharmaceuticals
Others
Application:
Chronic & Autoimmune Diseases
Oncology
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Biosimilar Monoclonal Antibody Industry Overview
-
1.1.1 Biosimilar Monoclonal Antibody Market Scope and Market Segments
-
1.1.2 Biosimilar Monoclonal Antibody Industry Characteristics
-
1.1.3 Global and China Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Biosimilar Monoclonal Antibody Production Value and Growth Rate (2017-2028)
-
1.2 Global Biosimilar Monoclonal Antibody Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Synthetic Chemicals
-
1.2.2 Biopharmaceuticals
-
1.2.3 Others
-
1.3 Global Biosimilar Monoclonal Antibody Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Chronic & Autoimmune Diseases
-
1.3.2 Oncology
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Biosimilar Monoclonal Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Biosimilar Monoclonal Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Biosimilar Monoclonal Antibody Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Biosimilar Monoclonal Antibody Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Biosimilar Monoclonal Antibody Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Biosimilar Monoclonal Antibody Industry Porter's Five Forces Model Analysis
-
2.2.3 Biosimilar Monoclonal Antibody Industry PEST Analysis
-
2.3 Biosimilar Monoclonal Antibody Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Biosimilar Monoclonal Antibody Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Biosimilar Monoclonal Antibody Industry
Chapter 3 Global and China Biosimilar Monoclonal Antibody Market, by Manufacturer
-
3.1 Global and China Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Biosimilar Monoclonal Antibody Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Biosimilar Monoclonal Antibody Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Biosimilar Monoclonal Antibody Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Biosimilar Monoclonal Antibody Market Top 3 Players
Chapter 4 Global and China Biosimilar Monoclonal Antibody Market, by Type (2017-2028)
-
4.1 Biosimilar Monoclonal Antibody Market Trend, by Type
-
4.2 Global Biosimilar Monoclonal Antibody Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Biosimilar Monoclonal Antibody Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Biosimilar Monoclonal Antibody Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Biosimilar Monoclonal Antibody Price Trend, by Type (2017-2028)
-
4.3 China Biosimilar Monoclonal Antibody Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Biosimilar Monoclonal Antibody Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Biosimilar Monoclonal Antibody Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Biosimilar Monoclonal Antibody Price Trend, by Type (2017-2028)
Chapter 5 Global and China Biosimilar Monoclonal Antibody Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Biosimilar Monoclonal Antibody Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Biosimilar Monoclonal Antibody Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Biosimilar Monoclonal Antibody Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Biosimilar Monoclonal Antibody Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Biosimilar Monoclonal Antibody Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Biosimilar Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Biosimilar Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Biosimilar Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Biosimilar Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Biosimilar Monoclonal Antibody Market Analysis
-
7.1 North America Biosimilar Monoclonal Antibody Market, by Type
-
7.2 North America Biosimilar Monoclonal Antibody Market, by Application
-
7.3 North America Biosimilar Monoclonal Antibody Market Analysis and Forecast, by Country
-
7.3.1 United States Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Biosimilar Monoclonal Antibody Market Analysis
-
8.1 Europe Biosimilar Monoclonal Antibody Market, by Type
-
8.2 Europe Biosimilar Monoclonal Antibody Market, by Application
-
8.3 Europe Biosimilar Monoclonal Antibody Market Analysis and Forecast, by Country
-
8.3.1 Germany Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Biosimilar Monoclonal Antibody Market Analysis
-
9.1 APAC Biosimilar Monoclonal Antibody Market, by Type
-
9.2 APAC Biosimilar Monoclonal Antibody Market, by Application
-
9.3 APAC Biosimilar Monoclonal Antibody Market Analysis and Forecast, by Country
-
9.3.1 China Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Market Analysis
-
10.1 Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Market, by Type
-
10.2 Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Market, by Application
-
10.3 Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Biosimilar Monoclonal Antibody Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Biosimilar Monoclonal Antibody Company Profiles
-
11.1 Therapeutics SA
-
11.1.1 Therapeutics SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Therapeutics SA Biosimilar Monoclonal Antibody Product Profiles, Application and Specification
-
11.1.3 Therapeutics SA Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Coherus BioSciences Inc
-
11.2.1 Coherus BioSciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Coherus BioSciences Inc Biosimilar Monoclonal Antibody Product Profiles, Application and Specification
-
11.2.3 Coherus BioSciences Inc Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Boehringer Ingelheim GmbH
-
11.3.1 Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibody Product Profiles, Application and Specification
-
11.3.3 Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Intas Pharmaceuticals Limited
-
11.4.1 Intas Pharmaceuticals Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibody Product Profiles, Application and Specification
-
11.4.3 Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 BIOCAD BioXpress
-
11.5.1 BIOCAD BioXpress Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 BIOCAD BioXpress Biosimilar Monoclonal Antibody Product Profiles, Application and Specification
-
11.5.3 BIOCAD BioXpress Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Allergan plc
-
11.6.1 Allergan plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Allergan plc Biosimilar Monoclonal Antibody Product Profiles, Application and Specification
-
11.6.3 Allergan plc Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Celltrion Inc
-
11.7.1 Celltrion Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Celltrion Inc Biosimilar Monoclonal Antibody Product Profiles, Application and Specification
-
11.7.3 Celltrion Inc Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Dr Reddys Laboratories Ltd
-
11.8.1 Dr Reddys Laboratories Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Dr Reddys Laboratories Ltd Biosimilar Monoclonal Antibody Product Profiles, Application and Specification
-
11.8.3 Dr Reddys Laboratories Ltd Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Genor BioPharma Co Ltd
-
11.9.1 Genor BioPharma Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Genor BioPharma Co Ltd Biosimilar Monoclonal Antibody Product Profiles, Application and Specification
-
11.9.3 Genor BioPharma Co Ltd Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Biocon Limited
-
11.10.1 Biocon Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Biocon Limited Biosimilar Monoclonal Antibody Product Profiles, Application and Specification
-
11.10.3 Biocon Limited Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Biosimilar Monoclonal Antibody Industry Investment Prospect and Risk Assessment
-
12.1 Biosimilar Monoclonal Antibody Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Biosimilar Monoclonal Antibody Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure China Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Production Value and Growth Rate (2017-2028)
-
Figure China Biosimilar Monoclonal Antibody Production Value and Growth Rate (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Market Size and Growth Rate of Synthetic Chemicals (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Market Size and Growth Rate of Biopharmaceuticals (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Market Size and Growth Rate of Chronic & Autoimmune Diseases (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Market Size and Growth Rate of Oncology (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Biosimilar Monoclonal Antibody Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Biosimilar Monoclonal Antibody Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Biosimilar Monoclonal Antibody Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Biosimilar Monoclonal Antibody Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Biosimilar Monoclonal Antibody Market Share, by Manufacturer in 2021
-
Figure Global and China Biosimilar Monoclonal Antibody Market Share, by Manufacturer in 2022
-
Table Global Biosimilar Monoclonal Antibody Sales Volume, by Type (2017-2028)
-
Table Global Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Table Global Biosimilar Monoclonal Antibody Sales Value, by Type (2017-2028)
-
Table Global Biosimilar Monoclonal Antibody Sales Value Share, by Type (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Price Trend, by Type (2017-2028)
-
Table China Biosimilar Monoclonal Antibody Sales Volume, by Type (2017-2028)
-
Table China Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Figure China Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Table China Biosimilar Monoclonal Antibody Sales Value, by Type (2017-2028)
-
Table China Biosimilar Monoclonal Antibody Sales Value Share, by Type (2017-2028)
-
Figure China Biosimilar Monoclonal Antibody Price Trend, by Type (2017-2028)
-
Table Global Biosimilar Monoclonal Antibody Sales Volume, by Application (2017-2028)
-
Table Global Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Table Global Biosimilar Monoclonal Antibody Sales Value, by Application (2017-2028)
-
Table Global Biosimilar Monoclonal Antibody Sales Value Share, by Application (2017-2028)
-
Figure Global Biosimilar Monoclonal Antibody Sales Value Share, by Application (2017-2028)
-
Table China Biosimilar Monoclonal Antibody Sales Volume, by Application (2017-2028)
-
Table China Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Figure China Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Table China Biosimilar Monoclonal Antibody Sales Value, by Application (2017-2028)
-
Table China Biosimilar Monoclonal Antibody Sales Value Share, by Application (2017-2028)
-
Figure China Biosimilar Monoclonal Antibody Sales Value Share, by Application (2017-2028)
-
Figure China Biosimilar Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure North America Biosimilar Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Biosimilar Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Biosimilar Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Production, Import, Consumption and Export (2017-2022)
-
Table North America Biosimilar Monoclonal Antibody Sales Volume, by Type (2017-2028)
-
Table North America Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Figure North America Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Table North America Biosimilar Monoclonal Antibody Sales Volume, by Application (2017-2028)
-
Table North America Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Figure North America Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Figure United States Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure United States Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Canada Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Table Europe Biosimilar Monoclonal Antibody Sales Volume, by Type (2017-2028)
-
Table Europe Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Figure Europe Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Table Europe Biosimilar Monoclonal Antibody Sales Volume, by Application (2017-2028)
-
Table Europe Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Europe Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Germany Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure UK Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure UK Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure France Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure France Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Italy Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Spain Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Poland Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Russia Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Table APAC Biosimilar Monoclonal Antibody Sales Volume, by Type (2017-2028)
-
Table APAC Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Figure APAC Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Table APAC Biosimilar Monoclonal Antibody Sales Volume, by Application (2017-2028)
-
Table APAC Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Figure APAC Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Figure China Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure China Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Japan Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure India Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure India Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilar Monoclonal Antibody Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Biosimilar Monoclonal Antibody Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Biosimilar Monoclonal Antibody Sales Value and Growth Rate (2017-2028)
-
Table Therapeutics SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Therapeutics SA Product Profiles, Application and Specification
-
Table Therapeutics SA Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Coherus BioSciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Coherus BioSciences Inc Product Profiles, Application and Specification
-
Table Coherus BioSciences Inc Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim GmbH Product Profiles, Application and Specification
-
Table Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Intas Pharmaceuticals Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Intas Pharmaceuticals Limited Product Profiles, Application and Specification
-
Table Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BIOCAD BioXpress Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BIOCAD BioXpress Product Profiles, Application and Specification
-
Table BIOCAD BioXpress Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Allergan plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Allergan plc Product Profiles, Application and Specification
-
Table Allergan plc Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Celltrion Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Celltrion Inc Product Profiles, Application and Specification
-
Table Celltrion Inc Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Dr Reddys Laboratories Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Dr Reddys Laboratories Ltd Product Profiles, Application and Specification
-
Table Dr Reddys Laboratories Ltd Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genor BioPharma Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genor BioPharma Co Ltd Product Profiles, Application and Specification
-
Table Genor BioPharma Co Ltd Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biocon Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biocon Limited Product Profiles, Application and Specification
-
Table Biocon Limited Biosimilar Monoclonal Antibody Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
